Lusaris Therapeutics

Lusaris Therapeutics

Lusaris Therapeutics pioneers next-generation psychedelic-inspired medicines for treating severe neuropsychiatric conditions like depression and anxiety.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $60M

About

Lusaris Therapeutics pioneers next-generation psychedelic-inspired medicines for treating severe neuropsychiatric conditions like depression and anxiety.

NeuroscienceSmall Molecules

Funding History

1
Total raised:$60M
Grant$60M